Effects of the German reference drug program on ex-factory prices of prescription drugs : a panel data approach
Year of publication: |
2009
|
---|---|
Authors: | Augurzky, Boris ; Göhlmann, Silja ; Greß, Stefan ; Wasem, Jürgen |
Published in: |
Health economics. - Chichester : Wiley-Blackwell, ISSN 1057-9230, ZDB-ID 1135838-5. - Vol. 18.2009, 4, p. 421-436
|
Subject: | Arzneimittel | Pharmaceuticals | Deutschland | Germany | Pharmaindustrie | Pharmaceutical industry | Panel | Panel study | Arzneimittelmarkt | Pharmaceutical market | Drogenkonsum | Drug consumption | Preis | Price | Schätzung | Estimation | Wirkungsanalyse | Impact assessment |
-
Financial and economic implications of Orphan drugs the Canadian economy in perspective
McGuire, John, (2014)
-
Do-It-Yourself medicine? : the impact of light cannabis liberalization on prescription drugs
Carrieri, Vincenzo, (2020)
-
Do-it-yourself medicine? : the impact of light cannabis liberalization on prescription drugs
Carrieri, Vincenzo, (2020)
- More ...
-
The effects of reference pricing on ex-factory prices of Rx drugs in Germany : a panel data approach
Augurzky, Boris, (2006)
-
The Effects of Reference Pricing on Ex-Factory Prices of Rx Drugs in Germany - a Panel Data Approach
Augurzky, Boris, (2006)
-
The Effects of Reference Pricing on Ex-factory Prices of Rx Drugs in Germany – A Panel Data Approach
Augurzky, Boris, (2006)
- More ...